for-6219
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 13, 2018 (NCT03709420)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
HSD17B1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04686669 | Phase 1 | Dec 31, 2020 | Forendo Pharma Ltd, Richmond Pharmacology |
| NCT03709420 | Phase 1 | Aug 13, 2018 | Forendo Pharma Ltd, Richmond Pharmacology |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Forendo Pharma Ltd | For profit | 2 | 2 | 1 | 2018 |
| Richmond Pharmacology | For profit | 2 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1